Reporting owner · Q3 2026 · CIK 1219927

Tabuteau Herriot: insider trades.

Tabuteau Herriot reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($22.5M), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
3
Companies
1
Name as filed
TABUTEAU HERRIOT

Companies

CompanyRelationshipTransactions
Axsome Therapeutics, Inc. (AXSM)Director, Officer, TenPercentOwner · Chief Executive Officer6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-06Axsome Therapeutics, Inc.S4,660$213.957,229Form 4
2026-08-06Axsome Therapeutics, Inc.M4,660$4.9511,889Form 4
2026-08-05Axsome Therapeutics, Inc.S45,004$212.017,229Form 4
2026-08-05Axsome Therapeutics, Inc.M45,004$4.9552,233Form 4
2026-07-01Axsome Therapeutics, Inc.M49,666$4.9556,895Form 4
2026-07-01Axsome Therapeutics, Inc.S49,666$240.257,229Form 4

Questions

What stock did Tabuteau Herriot buy or sell?

Tabuteau Herriot reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($22.5M), across 1 company.

Is Tabuteau Herriot the same person as other filers with this name?

This page covers SEC CIK 1219927 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/tabuteau-herriot-1219927.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.